Skip to main content
Back to Alumni Ventures

Alumni Ventures's Biotechnology Portfolio

Browse 43 Biotechnology companies funded by Alumni Ventures. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
43
Total Funding in Biotechnology
$1.3B

Biotechnology Portfolio Companies (43)

Export
BiotechnologyHealth CareTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

Philadelphia, United States
September 2022
$6.8M
Grant

Founder Contacts

30,000+ verified contacts

Big DataBiopharmaBiotechnologyLife ScienceMedical

Concerto Biosciences measures, maps, and utilizes microbes to create therapies and products for agriculture and human health industries.

Cambridge, United States
September 2024
Non-equity Assistance

Founder Contacts

30,000+ verified contacts

BioinformaticsBiotechnologyGeneticsHealth CareOncology

Mission Bio develops only single-cell multi-omics platform integrating genotype and phenotype for cancer research and biomarker development.

San Francisco, United States
August 2025
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsEnterprise SoftwareEventsLogisticsSoftware

Slope.io is a provider of a healthcare software designed to offer an easy way to prevent inventory outages.

San Francisco, United States
August 2024
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceNeuroscience

Kriya Therapeutics is a biopharmaceutical company that develops gene therapies for ophthalmology, neurology, and metabolic diseases.

Palo Alto, United States
August 2025
$320.8M
Series D

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyTherapeutics

Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.

Boston, United States
August 2025
$120.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth DiagnosticsMedicalPharmaceuticalTherapeutics

GRO Biosciences is a biotechnology company that develops a protein therapeutics technology to improve treatments across multiple diseases.

Boston, United States
July 2024
$60.3M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth Care

Seed develops clinically-studied probiotics to impact human and planetary health.

Venice, United States
July 2022
$925K
Undisclosed

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

Notable Labs provides personalized drug combination testing service for cancer patients.

Foster City, United States
July 2022
$189K
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyFood and BeverageFood ProcessingLife Science

Uncommon is about providing with that juicy, tender, and delicious meat they love but without harming their health, planet, and animals.

Cambridge, United Kingdom
June 2023
$30.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical Device

Shoulder Innovations is a medical device company that develops inset glenoid fixation technology.

Holland, United States
June 2026
$45.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalMen's

Contraline is a clinical-stage biotechnology company that develops male contraceptive solutions.

Charlottesville, United States
June 2026
$92.5M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyChemical EngineeringFood and BeverageFood ProcessingManufacturingWaste Management

Hyfé turns food waste into chemicals that maximize profits for food processors while allowing the world to make products without petroleum.

Chicago, United States
June 2023
$9.0M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Florence is a clinical trials platform that connects pharmaceutical companies and study sites to decentralize trials for drug development.

Atlanta, United States
June 2022
$27.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalPharmaceuticalTherapeutics

Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes.

Frederick, United States
June 2023
$24.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

B2BBiotechnologyPaaSPharmaceuticalSaaSSoftware

Clinical Maestro™ by Strategikon Pharma is the only commercially available software platform for clinical trial business management.

San Rafael, United States
June 2025
$2.3M
Debt Financing

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedicalTherapeutics

ParcelBio develops biotechnology focused on RNA medicine delivery systems and therapeutic development platforms.

San Francisco, United States
May 2026
$13.2M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceRobotics

Trilobio develops an automated laboratory platform that combines robotics, software, and tools to execute biological experiments.

San Francisco, United States
May 2025
$8.0M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyLife Science

Mapping interactions foundational to therapeutic discovery and human health.

Monmouth Junction, United States
May 2026
$48.0M
Series A

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyChemicalHealth CareLife ScienceMachine LearningPharmaceuticalQuantum ComputingTherapeutics

Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.

Palo Alto, United States
May 2023
Seed

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyMarket Research

Blank Bio is an applied AI research company developing RNA foundation models that analyze biological sequence data for therapeutic research.

San Francisco, United States
May 2026
Seed

Founder Contacts

30,000+ verified contacts

Advanced MaterialsBiotechnologyGreenTechPackaging ServicesSustainability

LOLIWARE is an award-winning materials tech company dedicated to replacing single-use plastics with seaweed.

San Francisco, United States
May 2026
$3.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyFood and BeverageWellness

Motif is a food technology company that offers plant-based and animal-free food options.

Boston, United States
May 2022
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

Biotechnology

Nanopath Inc. is a molecular diagnostics company enabling high-quality molecular testing in minutes.

Cambridge, United States
May 2025
$100K
Grant

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CarePrecision MedicineTherapeutics

Bionaut Labs revolutionizes the treatment of central nervous system disorders with its precision medicine treatment modality.

Los Angeles, United States
May 2024
$712K
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyTherapeutics

Swing Therapeutics provides digital therapeutics for people with chronic conditions.

San Francisco, United States
May 2026
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyFertilityHealth CareTherapeutics

Granata Bio is a biotechnology company developing therapeutic solutions to address infertility and improve women's reproductive health.

Duxbury, United States
May 2025
Corporate Round

Founder Contacts

30,000+ verified contacts

BiotechnologyCosmeticsHealth CareTherapeuticsWellness

Droplette is a needle-free and hand-held device that delivers large molecules deep through skin.

Cambridge, United States
May 2024
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

Alternative ProteinBiotechnology

Unicorn Biotechnologies develops compact, modular, intelligent hardware and software infrastructure that science can run on.

Sheffield, United Kingdom
April 2022
$3.2M
Seed

Founder Contacts

30,000+ verified contacts

AgTechAnimal FeedBiotechnology

Mootral is an AgriTech company focused on tackling two of the world's biggest crises: climate change and antimicrobial resistance (AMR).

Abertillery, United Kingdom
April 2022
$12.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedical Device

Nectero Medical develops a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms.

Tempe, United States
April 2024
$96.0M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical Device

Ossium Health builds a bone marrow bank to treat blood cancers.

San Francisco, United States
April 2026
$15K
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedical

Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering.

Newton, United States
March 2022
$82.5M
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife ScienceTherapeutics

HexemBio develops a synthetic human Yolk Sac platform to rejuvenate blood stem cells to extend healthy lifespan.

Los Angeles, United States
March 2026
$10.4M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareHealth DiagnosticsMedical

3X Genetics develops medical screening solutions to identify genetic disorders.

Worcester, United States
March 2026
$3.2M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalMental HealthPharmaceutical

Gilgamesh Pharmaceuticals is a clinical-stage biotechnology company that develops psychedelic and related drugs to treat mental illnesses.

New York, United States
March 2026
$60.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

SQZ Biotech features a cell engineering technology designed to deliver a diverse set of materials into patient cells.

Watertown, United States
March 2022
$2.0M
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalPharmaceutical

Emulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.

Boston, United States
March 2024
$47.1M
Series F

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife Science

Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.

La Jolla, United States
March 2026
$35.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyLife Science

Biotechnology company developing combination therapeutics for cancer

Redwood City, United States
March 2024
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyNutritionSoftware

Cyrus Biotechnology is a developer of Rosetta software platform that solves drug discovery problems.

Seattle, United States
February 2024
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife Science

Cambrian is a distributed development company building therapeutics to lengthen health span.

New York, United States
February 2026
$30.8M
Grant

Founder Contacts

30,000+ verified contacts

Alternative MedicineBiotechnologyGeneticsHealth CareHealth Diagnostics

Scipher Medicine develops a healthcare platform designed to determine which drug will work best for each patient.

Waltham, United States
February 2022
$110.0M
Series D

Founder Contacts

30,000+ verified contacts

Explore Alumni Ventures's Full Portfolio

View all companies funded by Alumni Ventures across every industry and funding stage.

View Full Alumni Ventures Portfolio